Literature DB >> 25201938

Promotion of family-centered birth with gentle cesarean delivery.

Susanna R Magee1, Cynthia Battle2, John Morton2, Melissa Nothnagle2.   

Abstract

PURPOSE: In this commentary we describe our experience developing a "gentle cesarean" program at a community hospital housing a family medicine residency program. The gentle cesarean technique has been popularized in recent obstetrics literature as a viable option to enhance the experience and outcomes of women and families undergoing cesarean delivery.
METHODS: Skin-to-skin placement of the infant in the operating room with no separation of mother and infant, reduction of extraneous noise, and initiation of breastfeeding in the operating room distinguish this technique from traditional cesarean delivery. Collaboration among family physicians, obstetricians, midwives, pediatricians, neonatologists, anesthesiologists, nurses, and operating room personnel facilitated the provision of gentle cesarean delivery to families requiring an operative birth.
RESULTS: Among 144 gentle cesarean births performed from 2009 to 2012, complication rates were similar to or lower than those for traditional cesarean births. Gentle cesarean delivery is now standard of care at our institution.
CONCLUSION: By sharing our experience, we hope to help other hospitals develop gentle cesarean programs. Family physicians should play an integral role in this process. © Copyright 2014 by the American Board of Family Medicine.

Entities:  

Keywords:  Birth; Breast Feeding; Cesarean Section; Family; Mother–Infant Interaction

Mesh:

Year:  2014        PMID: 25201938     DOI: 10.3122/jabfm.2014.05.140014

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  1 in total

1.  Neonatal Safety of Elective Family-Centered Caesarean Sections: A Cohort Study.

Authors:  Ilona C Narayen; Estelle E M Mulder; Kim E Boers; Jeroen J van Vonderen; Vera E R A Wolters; Liv M Freeman; Arjan B Te Pas
Journal:  Front Pediatr       Date:  2018-02-12       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.